Respiree Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
14
Respiree General Information
Description
Developer of AI-based breath-cardio sensors designed to improve patient outcomes and medicine at large. The company focuses on combating chronic respiratory diseases and mental health disorders by monitoring and recognizing abnormal changes in breathing and hemodynamic variability, enabling healthcare professionals to receive alerts in case of any clinical deterioration and offer diagnoses of cardio-respiratory diseases for their patients.
Contact Information
Website
www.respiree.comCorporate Office
- 23 Cantonment Road
- Number 05-05, The Centrepoint
- Singapore, 089743
- Singapore
Corporate Office
- 23 Cantonment Road
- Number 05-05, The Centrepoint
- Singapore, 089743
- Singapore
Respiree Timeline
Respiree Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 30-Oct-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 10-Jul-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 13-Jan-2025 | Completed | Generating Revenue | |||
| 4. Seed Round | 18-Jan-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 10-Sep-2020 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 31-Aug-2020 | Completed | Startup | |||
| 1. Seed Round | Completed | Startup |
Respiree Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Respiree Patents
Respiree Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026169215-A1 | Clinical deterioration event prediction | Pending | 10-Feb-2025 |
Respiree Signals
Respiree Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Texas Medical Center | Venture Capital | Minority | ||
| ARKRAY & PARTNERS | Corporate Venture Capital | |||
| Bizedge Capital | Venture Capital | Minority | ||
| ClavystBio | Venture Capital | Minority | ||
| Mayo Clinic Ventures | Corporate Venture Capital |
Respiree FAQs
-
When was Respiree founded?
Respiree was founded in 2019.
-
Where is Respiree headquartered?
Respiree is headquartered in Singapore, Singapore.
-
What is the size of Respiree?
Respiree has 40 total employees.
-
What industry is Respiree in?
Respiree’s primary industry is Monitoring Equipment.
-
Is Respiree a private or public company?
Respiree is a Private company.
-
What is Respiree’s current revenue?
The current revenue for Respiree is .
-
How much funding has Respiree raised over time?
Respiree has raised $15.2M.
-
Who are Respiree’s investors?
Texas Medical Center, ARKRAY & PARTNERS, Bizedge Capital, ClavystBio, and Mayo Clinic Ventures are 5 of 14 investors who have invested in Respiree.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process